PRESS RELEASE published on 10/14/2025 at 18:47, 1 year ago Spineway : Revenue growth in the third quarter Spineway Group reports 18% revenue growth in Q3 2025 driven by Premium ranges and strong performance in Latin America and Asia Revenue Growth Latin America Q3 2025 Premium Ranges Spineway Group
BRIEF published on 07/30/2025 at 19:29, 1 year 3 months ago Spineway: Half-yearly review 2025 and outlook Financial Results Treasury Growth Spineway Spinal Implants
PRESS RELEASE published on 07/30/2025 at 19:24, 1 year 3 months ago Spineway : H1 2025 results - Continued improvement in results and financial position Spineway reports improved H1 2025 results with net loss narrowing by €2 million. Revenue target for 2025 confirmed. Solid cash position of €4 million as of June 30, 2025 Revenue Growth Financial Performance Cash Position Spineway H1 2025 Results
BRIEF published on 06/06/2025 at 18:37, 1 year 5 months ago Spineway General Meeting Results PEA-PME Turnover General Assembly Resolutions Approved Spineway
PRESS RELEASE published on 06/06/2025 at 18:32, 1 year 5 months ago Spineway : Minutes of the General Meeting of June 4, 2025 Spineway shareholders approve multiple resolutions at General Meeting. Company eligible for PEA-SME. Details on website General Meeting Resolutions PEA-SME Exports Spineway
BRIEF published on 03/21/2025 at 08:50, 1 year 7 months ago Spineway legal proceedings against Strategos: new decision Arbitration Spineway Strategos Delaware Sentence
BRIEF published on 02/27/2025 at 18:35, 1 year 8 months ago Spineway stands out at Arab Health 2025 Middle East Distribution Spineway Arab Health 2025 Spinal Implants
BRIEF published on 12/04/2024 at 20:05, 1 year 11 months ago Spineway reduces its share capital by reducing the nominal value of the shares Actions Capital Reduction Sotck Exchange Nominal Value Spineway
PRESS RELEASE published on 12/04/2024 at 20:00, 1 year 11 months ago Spineway carries out a capital reduction by reducing the par value of its shares Spineway reduces share capital through a par value decrease to facilitate conversions and protect from compensation mechanisms. No impact on market value or outstanding shares Share Capital Reduction Spineway Par Value Decrease Compensation Mechanism Capital Reduction Impact
Published on 11/10/2026 at 14:45, 5 hours 17 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 5 hours 31 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 5 hours 32 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 5 hours 32 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 6 hours 2 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 18:54, 1 hour 7 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 1 hour 17 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 1 hour 32 minutes ago Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 18:20, 1 hour 41 minutes ago Edison issues report on Custodian Property Income REIT (LSE: CREI)
Published on 11/10/2026 at 17:31, 2 hours 30 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 6 hours 2 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 8 hours 59 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 13 hours 2 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 1 hour ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
